Holter Monitor CDSCO License — Import & Manufacturing Approval Process

Holter monitors are indispensable diagnostic devices in modern cardiac care. Used for continuous ambulatory ECG monitoring over 24 to 48 hours — or longer with extended recording models — Holter monitors enable cardiologists and electrophysiologists to detect arrhythmias, diagnose unexplained syncope, evaluate palpitations, and assess the effectiveness of antiarrhythmic therapy in patients going about their daily lives. With India’s growing burden of cardiovascular disease and a rapidly expanding cardiology infrastructure, the demand for Holter monitors across hospitals, cardiac diagnostic centres, and private cardiology practices is rising steadily.

Whether you are a foreign manufacturer seeking market entry in India, an Indian importer of international Holter monitor brands, or a domestic manufacturer of cardiac diagnostic devices, obtaining a CDSCO Licence is a mandatory legal requirement under the Medical Devices Rules, 2017 (MDR 2017). Distributing, importing, or manufacturing a Holter monitor without a valid licence is a criminal offence under the Drugs and Cosmetics Act, 1940.

We provide complete, end-to-end CDSCO registration services for Holter monitors — covering both the import licence pathway (Form MD-14 / MD-15) and the manufacturing licence pathway (Form MD-5 / MD-6) — with expert support at every stage from device classification through final licence issuance and post-market compliance.

What is CDSCO Holter Monitor Registration?

CDSCO registration is the formal process through which the Central Drugs Standard Control Organisation (CDSCO), operating under the Ministry of Health and Family Welfare, Government of India, evaluates a Holter monitor and grants a Market Authorisation (Medical Device Licence) permitting its commercial manufacture or import for sale in India.

All applications are filed through the CDSCO SUGAM online portal:

• Form MD-14 — Application for Import Licence (for Holter monitors manufactured outside India)
• Form MD-5 — Application for Manufacturing Licence (for Holter monitors manufactured in India)

Upon successful evaluation and approval:

• Form MD-15 — Import Licence is issued
• Form MD-6 — Manufacturing Licence is issued

Both licences are device-specific, manufacturer-specific, and valid for 5 years from the date of issue.

What is a Holter Monitor — Device Scope and Variants

A Holter monitor (also called an ambulatory ECG monitor or ambulatory electrocardiograph) is a portable, wearable medical device that continuously records the electrical activity of the heart over an extended period — typically 24 to 48 hours, though extended recording devices can monitor for 7 to 30 days or longer. The device is worn by the patient during normal daily activities, including sleep, and the recorded data is later analysed by a cardiologist using specialised analysis software.

The CDSCO registration requirement applies across the full spectrum of ambulatory cardiac monitoring technology:

Traditional Holter Monitors (24–48 Hour)

Wearable recording devices attached to the patient via electrode leads (typically 3, 5, or 12 leads), capturing a continuous ECG signal stored on flash memory or SD card for subsequent computer analysis. The most widely used format in Indian cardiology practices.

Extended Holter Monitors (7–30 Day Recording)

Devices designed for extended recording periods — particularly useful for detecting paroxysmal arrhythmias that may not be captured in a standard 24–48 hour recording. Smaller form factor, longer battery life, and typically wireless data transmission capabilities.

Patch-Based Ambulatory ECG Monitors

Adhesive patch devices that combine the electrode and recorder in a single, self-contained, waterproof unit. Applied directly to the patient’s chest for extended monitoring periods (typically 7 to 14 days). Examples include devices similar to the iRhythm Zio Patch format. Growing rapidly in adoption for both clinical and remote patient monitoring use.

Event Recorders (Cardiac Event Monitors)

Devices that continuously monitor cardiac rhythm but only store and transmit data when triggered — either automatically (when an arrhythmia is detected) or manually (when the patient presses a button upon experiencing symptoms). Used for intermittent symptom capture rather than continuous recording.

Mobile Cardiac Telemetry (MCT) Devices

Advanced ambulatory monitoring systems that combine Holter-style continuous recording with real-time wireless transmission to a monitoring centre, enabling immediate clinical review of serious arrhythmias detected during the monitoring period.

Implantable Loop Recorders (ILRs)

Subcutaneously implanted cardiac monitors for very long-term monitoring (up to 3 years) in patients with infrequent unexplained syncope or suspected paroxysmal arrhythmia. These are Class D devices and follow a distinct, more intensive registration pathway.

Holter Analysis Software (Standalone)

Software used to analyse and interpret Holter ECG recordings — if functioning as a standalone diagnostic software tool (independent of the recording hardware), it may require evaluation as a Software as a Medical Device (SaMD) under MDR 2017.

Regulatory Classification of Holter Monitors Under MDR 2017

Classification under the Medical Devices Rules, 2017 is the critical first step — it determines the conformity assessment route, documentation depth, licensing authority, and whether a Third Party Audit (TPA) is required.

Classification note: The classification of a Holter monitor depends not only on its recording duration but also on its connectivity features (real-time wireless transmission vs. store-and-forward), whether it includes automated arrhythmia detection algorithms, whether it is wearable or implantable, and the clinical decisions it influences. Our regulatory team conducts a formal, device-specific classification analysis before every application to ensure the correct pathway is selected from the outset.

Who Needs CDSCO Holter Monitor Registration?

• Foreign Holter monitor manufacturers — brands such as Spacelabs, Nasiff Associates, Rozinn/GE Healthcare, Welch Allyn, Meditech, Schiller, Biomedical Systems, iRhythm, Philips, and others seeking market access in India must appoint an Indian Authorised Agent (IAA) to file the import licence application
• Indian importers and distributors of international Holter monitor brands
• Domestic manufacturers of Holter monitors and ambulatory ECG recorders manufactured in India
• Cardiac diagnostic laboratories and cardiology equipment companies expanding their product portfolios
• MedTech startups developing novel ambulatory ECG monitoring solutions for the Indian market
• Hospitals and cardiac centres procuring Holter monitors — must purchase only CDSCO-registered devices
• Remote patient monitoring companies deploying wearable cardiac monitoring solutions in India
• Telemedicine and digital health platforms integrating certified ambulatory ECG devices into their service offerings

Complete Document Checklist for Holter Monitor CDSCO Registration

A complete, well-organised, and technically sound dossier is the single most important factor in achieving timely CDSCO approval. Below is the comprehensive, category-wise document checklist.

SECTION A — Indian Applicant / IAA Documents

1. Application in Form MD-14 (Import) or Form MD-5 (Manufacturing) Accurately completed application form filed through the CDSCO SUGAM portal with correct details of the applicant (IAA / importer / domestic manufacturer), the device manufacturer, and all Holter monitor models to be registered.

2. Business Registration Certificate Proof of legal existence of the Indian entity:

• Certificate of Incorporation (for Pvt Ltd / LLP / Public Ltd)
• Partnership Deed (for Partnership firms)
• LLP Agreement and Certificate of Incorporation (for LLPs)

3. Import Export Code (IEC) Valid IEC issued by the Directorate General of Foreign Trade (DGFT). Mandatory prerequisite for all import licence applications.

4. GST Registration Certificate Valid GSTIN of the Indian applicant entity.

5. Authorisation Letter from Foreign Manufacturer A formally notarised and apostilled letter from the overseas Holter monitor manufacturer, explicitly:

• Appointing the Indian entity as their authorised agent for the Indian market
• Listing all Holter monitor models and accessories covered by the authorisation
• Confirming the territory (India)
• Signed by a duly authorised officer of the foreign entity

6. Indian Authorised Agent (IAA) Agreement Formal agreement defining the regulatory roles and responsibilities of the IAA in India under MDR 2017 — covering vigilance reporting, label compliance, post-market surveillance, and communication with CDSCO.

7. Affidavit / Undertaking by Indian Applicant Sworn affidavit on non-judicial stamp paper from the proprietor / directors declaring compliance with MDR 2017 and the accuracy of all submitted information.

8. Power of Attorney (if filing through regulatory consultant) Duly executed POA authorising the regulatory consultant to file and manage the CDSCO application on the applicant’s behalf.

SECTION B — Device Technical Documents

9. Device Description and Intended Use A comprehensive written description covering:

• Full device name, model number(s), and all product variants in the application
• Operating principle — how the device records, stores, and transmits cardiac electrical signals
• Recording modality — number of channels (single-lead, 3-lead, 5-lead, 12-lead), recording duration, data storage method (flash memory, SD card, cloud)
• Intended clinical use — arrhythmia detection, syncope evaluation, palpitation assessment, therapy monitoring, atrial fibrillation screening, etc.
• Intended clinical setting — outpatient cardiology clinic, hospital, home use, remote monitoring
• Intended users — clinical professionals, trained technicians, or patients (for self-applied patch monitors)
• Intended patient population — adult, paediatric (if applicable)
• Contraindications and clinical limitations
• Description of all system components — recording unit, electrodes/leads/patches, patient cable, data reader/download station, analysis software
• Description of wireless connectivity and data transmission features (Bluetooth, Wi-Fi, cellular)
• Description of any automated arrhythmia detection algorithms embedded in the device

10. Technical Specifications Detailed performance specifications including:

• Number of recording channels
• Sampling rate (Hz per channel)
• ADC resolution (bits)
• Frequency response range (Hz) — compliant with applicable standards
• Input impedance
• Common mode rejection ratio (CMRR)
• Amplitude accuracy
• Recording duration and memory capacity
• Battery type and life (recording duration per battery charge)
• Data storage format
• Communication interfaces — USB, Bluetooth, Wi-Fi, cellular (with protocols)
• Dimensions and weight of the recording unit
• Electrode / patch type and attachment method
• IP rating (water and dust resistance — particularly important for extended-wear patch monitors)
• Operating temperature and humidity range
• Patient isolation specifications (Type B, BF, or CF — per IEC 60601-1)
• Analysis software specifications — supported operating systems, AI/algorithm features, reporting formats

11. Essential Principles Checklist (Schedule III — MDR 2017) A comprehensive demonstration of how the Holter monitor satisfies each applicable Essential Principle of Safety and Performance under Schedule III of MDR 2017 — with specific references to applicable standards, test reports, and clinical / technical evidence for each principle.

12. Risk Management File (ISO 14971:2019) Complete risk management documentation covering:

• Risk management plan
• Hazard identification — including signal acquisition errors, ECG artifact, missed arrhythmia detection, false positive arrhythmia alerts, lead failure, battery failure, data corruption, software errors, electromagnetic interference, skin irritation from electrodes (for patch monitors), and patient data security risks
• Risk estimation and evaluation for each identified hazard
• Risk control measures and verification of their effectiveness
• Residual risk assessment and acceptability
• Benefit-risk analysis conclusion
• Post-production information input and update process

13. Software Documentation (IEC 62304) All modern Holter monitors incorporate embedded firmware and analysis software — both of which fall under medical device software requirements:

Embedded Firmware (Recording Device):

• Software description and architecture
• Software safety classification per IEC 62304 (typically Class B for recording firmware — Class C if the firmware includes automated arrhythmia detection that directly influences clinical decisions)
• Software development lifecycle documentation
• Verification and validation records
• Software version history and change control

Analysis Software (Holter Workstation / Cloud Platform):

• Software description — operating system compatibility, data import/export, arrhythmia detection algorithm, reporting features
• Software safety classification per IEC 62304
• Algorithm validation — sensitivity and specificity data for automated arrhythmia detection
• Cybersecurity risk assessment per IEC 81001-5-1 — particularly important for cloud-connected and mobile app-integrated systems
• Mobile app regulatory status (if a companion app is used for data viewing or patient-facing functions)

14. Arrhythmia Detection Algorithm Documentation For Holter monitors with embedded or software-based automated arrhythmia detection:

• Algorithm description and operating principle
• Validation data — sensitivity and specificity for detection of clinically significant arrhythmias (atrial fibrillation, ventricular tachycardia, AV block, bradycardia, tachycardia, pause events)
• False positive and false negative rates
• Algorithm performance in the presence of common ECG artifacts (motion, noise, poor electrode contact)
• Clinical data supporting algorithm performance claims

15. Usability Engineering File (IEC 62366-1) Documentation of the usability engineering process for the Holter monitor:

• Intended use environment analysis (outpatient clinic, patient home, cardiology lab)
• User population analysis — clinical professionals, non-specialist nurses, patients (for self-applied patch monitors)
• Identification of use-related hazards — incorrect lead placement, patient interference with recording, inappropriate data interpretation
• Formative usability evaluations during design development
• Summative usability evaluation (human factors validation study)
• Residual use-related risk assessment

This is especially important for patch-based ambulatory ECG monitors and event recorders where patients self-apply the device without clinical supervision.

16. Biocompatibility Documentation (ISO 10993 Series) For all patient-contacting components of the Holter monitor:

• Electrode adhesives and gels — skin contact biocompatibility (ISO 10993-5 cytotoxicity, ISO 10993-10 sensitisation, ISO 10993-23 irritation)
• Patch monitor housing materials — skin contact biocompatibility
• Patient cable and connector materials

Biocompatibility is a critical area for extended-wear patch monitors where the device is in continuous skin contact for 7 to 14 days — the potential for skin irritation, sensitisation, and allergic reactions requires thorough testing and documentation.

SECTION C — Test Reports and Standards Compliance

All test reports must be issued by NABL-accredited laboratories or internationally accredited laboratories (ILAC MRA members — A2LA, UKAS, DAkkS, etc.).

17. IEC 60601-1 — General Safety and Essential Performance The foundational standard for all electrically powered medical devices. Covers electrical safety (patient leakage current, earth leakage, dielectric strength), mechanical safety, thermal safety, and essential performance requirements. Mandatory for all Holter monitors.

18. IEC 60601-1-2 — Electromagnetic Compatibility (EMC) Ensures the Holter monitor does not emit electromagnetic interference affecting other devices and operates correctly in environments with common EMC sources (mobile phones, hospital equipment, household electronics). Particularly important for wearable devices that operate in uncontrolled environments.

19. IEC 60601-1-6 — Usability General usability requirements for medical electrical equipment — complements the IEC 62366-1 usability engineering file.

20. IEC 60601-1-11 — Home Healthcare Environment (if applicable) For Holter monitors intended for use in home care settings — additional requirements for the home electromagnetic environment, power supply variation, and physical environmental robustness. Applicable to all ambulatory devices used outside controlled clinical settings.

21. IEC 60601-2-25 — Electrocardiographs Particular requirements for basic safety and essential performance of electrocardiographs — covering ECG signal acquisition accuracy, frequency response, amplitude accuracy, time accuracy, and noise performance. This is the primary product-specific standard for Holter monitors and ambulatory ECG devices.

Key performance parameters specified in IEC 60601-2-25:

• Frequency bandwidth (0.05–150 Hz for diagnostic quality; 0.5–40 Hz for monitoring quality)
• Amplitude accuracy (±5% or ±0.05 mV, whichever is greater)
• Time accuracy
• Noise level limits (≤10 μVpp)
• Input impedance (≥10 MΩ at 10 Hz)
• CMRR (≥80 dB at 50/60 Hz)
• Baseline stability and recovery after defibrillation (for devices used in environments where defibrillation may occur)

22. IEC 60601-2-47 — Ambulatory Electrocardiographic Systems This is the dedicated product standard specifically for Holter monitors and ambulatory ECG systems — covering particular requirements for basic safety and essential performance unique to ambulatory (wearable, portable) ECG recording. Requirements include:

• Ambulatory-specific noise and artifact performance
• Battery-powered operation requirements
• Data storage and retrieval requirements
• Analysis software accuracy requirements
• Ambulatory-specific electrode performance
• Label and documentation requirements specific to ambulatory systems

IEC 60601-2-47 compliance is the most important single test requirement for Holter monitor CDSCO registration and must be a primary focus of test report procurement.

23. IEC 62304 — Medical Device Software Mandatory for all Holter monitors with embedded firmware and analysis software — covering software lifecycle processes from development through maintenance.

24. IEC 62366-1 — Usability Engineering Test report or evaluation evidence demonstrating usability validation — particularly important for patient-applied patch monitors.

25. IP Rating Test (IEC 60529) — if applicable For extended-wear patch monitors and water-resistant Holter monitors, the IP rating (e.g., IP67 for dust-tight and immersion-resistant) must be validated through standardised ingress protection testing.

26. Biocompatibility Test Reports (ISO 10993 Series) Laboratory test reports for patient-contacting materials — covering cytotoxicity, sensitisation, and irritation as minimum for skin-contacting components.

SECTION D — Quality Management System Documents

27. ISO 13485:2016 Certificate Valid ISO 13485 QMS certificate from an accredited certification body, with a product scope that explicitly covers electrocardiography devices, ambulatory monitoring systems, or cardiac diagnostic devices. Must be current and within validity at the time of application.

28. Quality Management System Overview Summary of the manufacturer’s QMS — quality policy, organisational structure, key processes, and how the system ensures continued compliance of Holter monitors placed on the market.

29. Post-Market Surveillance (PMS) Plan Documented plan for systematic collection, review, and action on post-market data about the device’s real-world safety and performance. Must include:

• Data sources — customer feedback, complaint tracking, published literature, global safety databases (FDA MAUDE, EUDAMED)
• Review frequency and responsible personnel
• Criteria for triggering corrective actions
• Integration with risk management process

30. Vigilance Procedures Documented procedures for:

• Detecting and evaluating serious incidents involving the Holter monitor (missed arrhythmia detection leading to patient harm, device failure during monitoring, skin reactions from electrodes)
• Reporting to CDSCO within prescribed timeframes (typically 30 days for serious incidents; immediate reporting for certain critical events)
• Managing Field Safety Corrective Actions (device recalls, software updates with safety implications, advisory notices)
• Communicating Field Safety Notices to hospital customers and cardiac diagnostic labs

31. Periodic Safety Update Report (PSUR) — if available For devices already marketed in other countries — a PSUR summarising post-market safety and performance data, benefit-risk conclusions, and corrective actions — demonstrating the device’s real-world safety profile.

SECTION E — Clinical Evaluation Documents

32. Clinical Evaluation Report (CER) A systematic, documented evaluation of clinical data demonstrating that the Holter monitor achieves its intended clinical performance — accurate, reliable ambulatory ECG recording for the detection and characterisation of cardiac arrhythmias — and is safe for the intended patient population. The CER must:

• Reference and summarise the published clinical literature on Holter monitoring for the intended clinical indications (arrhythmia detection, syncope evaluation, AF screening, etc.)
• Include clinical performance data from the specific device or from a rigorously justified equivalent device
• Address the clinical performance of the arrhythmia detection algorithm (where applicable)
• For patch monitors and MCT devices — reference clinical validation studies specific to the device format
• Conclude on the adequacy of clinical evidence for the intended clinical claims

33. Clinical Investigation Data (if applicable) For novel Holter monitor designs, new arrhythmia detection algorithms, new patch monitor formats, or new clinical indications not supported by equivalent device data — clinical investigation results may be required.

34. Post-Market Clinical Follow-Up (PMCF) Plan A documented plan for continued collection of clinical data after market entry in India — feeding into the ongoing clinical evaluation cycle and supporting evidence of continued acceptability of the device’s clinical benefit-risk profile.

SECTION F — Labelling and Instructions for Use

35. Device Label (Schedule V — MDR 2017) Proposed label for the Holter monitor device and its packaging, including all mandatory elements:

• Device name and model number
• Manufacturer’s name, address, and contact details
• Country of manufacture
• Indian Authorised Agent’s name, address, and contact details
• Unique Device Identification (UDI) — GTIN, serial number / lot number
• Manufacturing date
• Single-use designation (for disposable electrodes / patches)
• Sterility indicator (for sterile electrodes / patches, if applicable)
• Battery type and replacement instructions
• Applicable symbols (ISO 15223, IEC 60601)
• Environmental storage and transport conditions
• IP rating (for water-resistant models)

36. Instructions for Use (IFU) / User Manual Comprehensive user documentation covering:

• Intended use and clinical indications
• Contraindications and precautions
• Patient preparation — skin preparation, electrode placement guide with diagrams
• Device setup and configuration for recording
• Lead / electrode attachment procedures (for traditional monitors)
• Patch application procedure (for patch monitors)
• Patient diary instructions
• Data download and transfer procedure
• Analysis software operation guide — data import, automated analysis review, manual editing, report generation
• ECG quality verification procedures
• Battery management and replacement
• Device cleaning and maintenance
• Electrode / patch storage and handling
• Troubleshooting guide
• Technical specifications
• Accessories list and ordering information
• Disposal and recycling instructions

SECTION G — Documents from Foreign Manufacturer

37. Free Sale Certificate (FSC) / Market Authorisation Issued by the competent regulatory authority in the manufacturer’s home country:

• USA: FDA 510(k) clearance (most Holter monitors)
• European Union: CE Certificate under EU MDR 2017/745 or MDD 93/42/EEC from an EU Notified Body
• Australia: TGA ARTG registration
• Canada: Health Canada Medical Device Licence
• Japan: PMDA approval

Must be apostilled or legalised by the Indian Embassy / Consulate in the manufacturer’s country.

38. Manufacturing Licence of Foreign Facility Documentary proof that the manufacturing site holds a valid manufacturing licence or equivalent regulatory authorisation in the country of manufacture.

39. GMP Compliance Certificate Evidence of Good Manufacturing Practices compliance at the manufacturing facility — ISO 13485 certificate or equivalent (FDA Establishment Registration, CE Annex certification).

40. Site Master File (SMF) Comprehensive document describing the manufacturing site — location, infrastructure, quality systems, manufacturing processes, and regulatory compliance history.

41. Declaration of Conformity Formal declaration by the foreign manufacturer that the Holter monitor conforms to all applicable requirements of the Medical Devices Rules, 2017 and meets all Essential Principles of Safety and Performance.

Step-by-Step CDSCO Registration Process for Holter Monitors

Step 1 — Free Regulatory Assessment and Device Classification

Our team reviews your Holter monitor’s specifications, intended use, software features, and existing certifications to determine the correct MDR 2017 classification and identify the applicable registration pathway.

Step 2 — Documentation Gap Analysis

We systematically compare all available technical documents against CDSCO requirements — identifying missing standards, incomplete software documentation, clinical evidence gaps, expired ISO 13485 certificates, or IFU deficiencies.

Step 3 — Software and Algorithm Documentation Review

We specifically review IEC 62304 software documentation and arrhythmia detection algorithm validation data — two areas where Holter monitor dossiers frequently have gaps that trigger CDSCO queries.

Step 4 — Biocompatibility Assessment Review

For patch monitors and extended-wear devices, we specifically review ISO 10993 biocompatibility documentation for all skin-contacting materials — identifying gaps in sensitisation, irritation, and cytotoxicity testing.

Step 5 — Foreign Manufacturer Document Coordination

We work with you and the overseas manufacturer to obtain all required foreign documents — FSC, SMF, ISO 13485 certificate, Declaration of Conformity, and authorisation letter — and coordinate apostille / legalisation.

Step 6 — Technical Dossier Preparation

We prepare or review the complete dossier — Essential Principles Checklist, Risk Management File, Clinical Evaluation Report, usability documentation, software documentation, and labelling — to CDSCO-submission standard.

Step 7 — Test Report Verification

We verify that all required IEC test reports — especially IEC 60601-2-25 and IEC 60601-2-47 — are available, current, and from acceptable laboratories. We advise on missing or expiring test reports and coordinate additional testing.

Step 8 — SUGAM Portal Application Filing

We manage the complete SUGAM portal submission — Form MD-14 / MD-5, document upload, and government fee payment.

Step 9 — TPA Coordination (if applicable)

For Class C devices (MCT, higher-class extended Holter monitors), we prepare the dossier for Third Party Audit review, manage TPA communication, and respond to audit findings.

Step 10 — CDSCO Query Response

Our regulatory experts prepare technically precise, well-documented written responses to all CDSCO queries — addressing ECG performance data, algorithm validation, software classification, and clinical evidence as required.

Step 11 — Licence Issuance and Post-Licence Onboarding

Upon approval, we deliver the MD-15 or MD-6 licence with a complete explanation of post-registration compliance obligations — vigilance reporting timelines, PSUR schedule, label compliance requirements, and UDI registration.

Government Fee for Holter Monitor CDSCO Registration

Government fees are paid online through the SUGAM portal and are subject to revision by the Government of India.

Estimated Timeline for Holter Monitor CDSCO Registration

Timelines depend on documentation completeness, CDSCO workload, TPA scheduling (for Class C/D), and response speed on queries.

Post-Registration Compliance Obligations

Label Compliance Every Holter monitor unit placed on the Indian market must bear an MDR 2017 Schedule V compliant label — including the IAA’s name and address, UDI, and all other mandatory elements.

Vigilance Reporting Serious incidents — device malfunction causing missed arrhythmia detection, patient skin reactions from electrodes, data loss during monitoring — must be reported to CDSCO within prescribed timeframes.

Post-Market Surveillance Continuous monitoring of real-world device performance, customer and clinician feedback, and global safety signals from FDA MAUDE, EUDAMED, and other vigilance databases must be maintained.

Software Update Notifications Algorithm updates, firmware changes, or analysis software updates that affect device safety, performance, or intended use must be notified to CDSCO before deployment.

Periodic Safety Update Reports (PSURs) Class C Holter and MCT devices require periodic PSURs — summarising post-market safety and performance data and benefit-risk conclusions.

Renewal Before Expiry The MD-15 or MD-6 licence must be renewed before its 5-year expiry date. We provide renewal tracking and manage the renewal process as part of our post-registration support.

Why Choose Our CDSCO Registration Services for Holter Monitors?

Ambulatory Cardiac Device Expertise We have specific experience registering ambulatory ECG and Holter monitoring devices with CDSCO — including traditional Holter recorders, patch monitors, event recorders, and MCT systems. We understand the unique classification nuances and documentation requirements of this device category.

IEC 60601-2-47 Specialisation The ambulatory ECG systems standard — IEC 60601-2-47 — is the most critical test for Holter monitor registration and the standard where test gaps most frequently occur. Our team specifically verifies compliance with IEC 60601-2-47 alongside IEC 60601-2-25 for every application.

Algorithm Validation and Software Documentation Algorithm validation data and IEC 62304 software documentation are the two areas most likely to attract CDSCO queries for Holter monitor applications. We specialise in reviewing and strengthening these sections of the technical dossier.

Biocompatibility for Extended-Wear Monitors For patch-based and extended-wear devices, biocompatibility of skin-contacting materials over extended periods requires specific ISO 10993 documentation. We identify biocompatibility documentation gaps early — before they become CDSCO queries.

Patch Monitor and MCT Regulatory Experience Newer ambulatory ECG formats — particularly patch monitors and MCT devices — present unique classification challenges and documentation requirements. We have specific experience with these emerging device categories.

End-to-End Accountability From the first free consultation through MD-15 / MD-6 issuance and ongoing post-market compliance, we take full accountability for your Holter monitor CDSCO registration — at every step.

Frequently Asked Questions (FAQs)

Q1. Is CDSCO registration mandatory for all Holter monitors sold in India?

Yes. All Holter monitors and ambulatory ECG systems — whether imported or domestically manufactured — are regulated medical devices under Schedule I of the Medical Devices Rules, 2017 and require CDSCO registration (MD-15 for imports, MD-6 for domestic manufacture) before commercial sale.

Q2. Can a cardiology hospital or diagnostic lab import a Holter monitor for its own use without CDSCO registration?

No. CDSCO registration is required regardless of whether the device is for commercial sale or institutional end-use. Government hospital procurement, GeM procurement, and institutional tenders all mandate CDSCO registration.

Q3. What is the difference between IEC 60601-2-25 and IEC 60601-2-47 — and do I need both?

IEC 60601-2-25 is the general electrocardiograph standard covering ECG signal quality requirements. IEC 60601-2-47 is the specific ambulatory ECG systems standard covering requirements unique to wearable, portable recording systems. For Holter monitors, both standards apply — and test reports for both must be included in the CDSCO dossier.

Q4. My Holter monitor has a companion mobile app for patient data viewing and physician report access. Does the app need separate CDSCO registration?

If the app is purely a data viewer or patient convenience interface without performing any independent diagnostic function, it is typically considered an accessory to the registered device and is covered by the device registration. If the app independently performs arrhythmia detection, clinical decision support, or diagnostic functions, it may need to be evaluated as a Software as a Medical Device (SaMD) — potentially requiring separate registration. Our team can assess the regulatory status of your companion app.

Q5. Is CE marking under EU MDR sufficient to sell Holter monitors in India?

No. CE certification documents are submitted as the Free Sale Certificate supporting the CDSCO application but do not substitute for a separate Indian CDSCO registration. India requires an independent registration process through CDSCO.

Q6. We want to register both our standard 24-hour Holter monitor and our 7-day patch monitor. Can these be covered under a single CDSCO application?

Generally, they require separate applications — particularly if they are different device platforms with different technical documentation, different software, and different risk classifications. Our team can assess whether any variant strategy is possible and advise on the most efficient portfolio registration approach.

Q7. What is a Third Party Audit (TPA) and which Holter devices require it?

A TPA is an independent review of the technical dossier by a CDSCO-appointed auditor — mandatory for Class C and Class D devices. Standard 24/48-hour Holter monitors (Class B) typically do not require TPA. Mobile Cardiac Telemetry (MCT) devices and Implantable Loop Recorders (ILRs) — which are Class C and Class D respectively — require TPA.

Q8. What happens if I sell an unregistered Holter monitor in India?

Importing, distributing, or selling an unregistered medical device is a criminal offence under the Drugs and Cosmetics Act, 1940. Consequences include product seizure and destruction, cancellation of IEC and business licences, financial penalties, imprisonment of up to 3 years, and reputational damage. Hospitals and diagnostic labs procuring unregistered devices also face regulatory exposure.